Efficacy and safety of daridorexant for the treatment of insomnia disorder in women of menopausal transition age: Insights from a randomized controlled trial.

Schaedel Z, Bakker TR, Bassetti C, Briasoulis O, Cassel P, Pain S, Palacios S, Palmay C, Silvestri R, Stute P, Trémollieres F, Bertisch SM

Open source

DOI
10.1016/j.maturitas.2025.108821
Published
2026 Mar
Container
Maturitas
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.maturitas.2025.108821,
  title = {Efficacy and safety of daridorexant for the treatment of insomnia disorder in women of menopausal transition age: Insights from a randomized controlled trial.},
  author = {Schaedel Z and Bakker TR and Bassetti C and Briasoulis O and Cassel P and Pain S and Palacios S and Palmay C and Silvestri R and Stute P and Trémollieres F and Bertisch SM},
  year = {2026},
  journal = {Maturitas},
  doi = {10.1016/j.maturitas.2025.108821},
  url = {https://doi.org/10.1016/j.maturitas.2025.108821}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of daridorexant for the treatment of insomnia disorder in women of menopausal transition age: Insights from a randomized controlled trial.
AU  - Schaedel Z
AU  - Bakker TR
AU  - Bassetti C
AU  - Briasoulis O
AU  - Cassel P
AU  - Pain S
AU  - Palacios S
AU  - Palmay C
AU  - Silvestri R
AU  - Stute P
AU  - Trémollieres F
AU  - Bertisch SM
PY  - 2026
JO  - Maturitas
DO  - 10.1016/j.maturitas.2025.108821
UR  - https://doi.org/10.1016/j.maturitas.2025.108821
ER  - 

APA

Z, S., TR, B., C, B., O, B., P, C., S, P., S, P., C, P., R, S., P, S., F, T., & SM, B. (2026). Efficacy and safety of daridorexant for the treatment of insomnia disorder in women of menopausal transition age: Insights from a randomized controlled trial.. Maturitas. https://doi.org/10.1016/j.maturitas.2025.108821

Source records